These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon.
    Author: Lukas SE, Brady JV, Griffiths RR.
    Journal: J Pharmacol Exp Ther; 1986 Sep; 238(3):924-31. PubMed ID: 3746670.
    Abstract:
    Eight opioid agonist, mixed agonist/antagonist or antagonist compounds were compared in baboons. In the first experiment, i.v. drug self-injection procedures involved a fixed-ratio schedule with a 3 hr time-out after each injection. Doses of a test drug were substituted for cocaine for 12 or 15 days. Codeine, morphine, butorphanol, nalbuphine and pentazocine all maintained self-injection above vehicle control levels. These compounds differed in their relative potencies, and morphine did not maintain maximal drug self-injection rates. Buprenorphine maintained self-injection in only one of four baboons, and SKF-10,047 and naloxone did not maintain self-injection. In a second experiment, another group of baboons responded on a fixed-ratio 50 schedule of food pellet delivery. Intravenous injections were given 30 min before test sessions that lasted 30 min. All eight drugs produced dose-related decreases in response rates, and the buprenorphine dose-response curve was more shallow and not parallel to the others. Comparison across experiments suggested that the failure of morphine to maintain maximal self-injection rates is due to its relatively high potency in suppressing schedule-controlled performance. The results of this study confirm those of previous studies demonstrating that opioids with morphine-like subjective effects in man are self-administered by laboratory animals.
    [Abstract] [Full Text] [Related] [New Search]